imap Research

iMAP Research is a biotechnology company focused on the development of advanced molecular analysis tools and therapeutic strategies for oncology and autoimmune diseases. The company utilizes its proprietary Integrated Molecular Analysis Platform (iMAP) to identify novel biomarkers and therapeutic targets with high precision. By integrating multi-omics data, iMAP Research aims to accelerate the drug discovery process and enable personalized medicine approaches. Their current pipeline includes several pre-clinical programs targeting immune checkpoints and inflammatory pathways. The company's mission is to transform complex biological data into actionable clinical insights to improve patient outcomes.